Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malaria

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 72 articles: HTML format

Single Articles

November 2023
1. VAN SCHALKWYK DA, Pratt S, Nolder D, Stewart LB, et al
   Treatment failure in a UK malaria patient harbouring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and lumefantrine.
   Clin Infect Dis. 2023 Nov 29:ciad724. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2023
2. COUGHLAN C, Jager HR, Brealey D, Carletti F, et al
   Adult cerebral malaria: acute and subacute imaging findings, long-term clinical consequences.
   Clin Infect Dis. 2023 Oct 28:ciad651. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. CASTRO L, Ridpath A, Mace K, Gutman JR, et al
   Have you heard the news? Artemether-lumefantrine is now recommended for ALL uncomplicated malaria in the United States, including in pregnancy.
   Clin Infect Dis. 2023 Oct 17:ciad638. doi: 10.1093.
   PubMed    
   
   
   July 2023
4. KAPISI J, Sserwanga A, Kitutu FE, Rutebemberwa E, et al
   Impact of the Introduction of a Package of Diagnostic Tools, Diagnostic Algorithm, and Training and Communication on Outpatient Acute Fever Case Management at 3 Diverse Sites in Uganda: Results of a Randomized Controlled Trial.
   Clin Infect Dis. 2023;77.
   PubMed     Abstract available
   
   
   
5. KIEMDE F, Valia D, Kabore B, Rouamba T, et al
   A Randomized Trial to Assess the Impact of a Package of Diagnostic Tools and Diagnostic Algorithm on Antibiotic Prescriptions for the Management of Febrile Illnesses Among Children and Adolescents in Primary Health Facilities in Burkina Faso.
   Clin Infect Dis. 2023;77.
   PubMed     Abstract available
   
   
   May 2023
6. CHU CS, Stolbrink M, Stolady D, Saito M, et al
   Severe falciparum and vivax malaria on the Thailand-Myanmar border: A review of 1503 cases.
   Clin Infect Dis. 2023 May 5:ciad262. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2023
7. UWIMANA A, Sethi R, Murindahabi M, Ntirandeka C, et al
   Effectiveness of intermittent screening and treatment of malaria in pregnancy on maternal and birth outcomes in selected districts in Rwanda: A cluster randomized controlled trial.
   Clin Infect Dis. 2023 Mar 10:ciad128. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2023
8. WHITE NJ
   The antimalarial activity of tafenoquine in falciparum malaria.
   Clin Infect Dis. 2023 Feb 16:ciad079. doi: 10.1093.
   PubMed    
   
   
   
9. BARBER BE, Abd-Rahman AN, Webster R, Potter AJ, et al
   Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
   Clin Infect Dis. 2023 Feb 16:ciad075. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. BLANKEN SL, Soumare HDM, Andolina C, Lanke K, et al
    How to Interpret Parasite Persistence and Transmission to Mosquitoes After Antimalarial Treatment in Kenya?
    Clin Infect Dis. 2023;76:555-557.
    PubMed    
    
    
    
11. LE GOFF M, Kendjo E, Thellier M, Piarroux R, et al
    Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
    Clin Infect Dis. 2023;76:e884-e893.
    PubMed     Abstract available
    
    
    
12. SCHULTZ JS, Mace KE, Tan KR
    Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria.
    Clin Infect Dis. 2023 Feb 1:ciad061. doi: 10.1093.
    PubMed    
    
    
    December 2022
13. FUKUDA N, Balikagala B, Ueno T, Anywar DA, et al
    The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
    Clin Infect Dis. 2022 Dec 15:ciac944. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
14. BANGIRANA P, Conroy AL, Opoka RO, Semrud-Clikeman M, et al
    Effect of malaria and malaria chemoprevention regimens in pregnancy and childhood on neurodevelopmental and behavioral outcomes in children at 12, 24 and 36 months: a randomized clinical trial.
    Clin Infect Dis. 2022 Oct 11. pii: 6758421. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. COPPEE R, Sarrasin V, Zaffaroulah R, Bouzayene A, et al
    Nosocomial malaria transmissions resolved by genomic analyses - a retrospective case report study in France (2007-2021).
    Clin Infect Dis. 2022 Oct 8. pii: 6754169. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
16. WHALEN ME, Kajubi R, Goodwin J, Orukan F, et al
    The impact of extended treatment with artemether-lumefantrine on antimalarial exposure and reinfection risks in Ugandan children with uncomplicated malaria: A randomized controlled trial.
    Clin Infect Dis. 2022 Sep 20. pii: 6708265. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. THOMAS CM, Stauffer WM, Alpern JD
    FDA Approval of Artesunate for Severe Malaria-Enough to Achieve Best Practice?
    Clin Infect Dis. 2022 Sep 3. pii: 6691362. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. ABANYIE F, Ng J, Tan KR
    Post-Artesunate Delayed Hemolysis in Patients with Severe Malaria in the United States-April 2019 Through July 2021.
    Clin Infect Dis. 2022 Sep 2. pii: 6686391. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
19. HUGHES E, Wallender E, Kajubi R, Jagannathan P, et al
    Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Clin Infect Dis. 2022;75:406-415.
    PubMed     Abstract available
    
    
    July 2022
20. LI Y, Stewart K, Han KT, Han ZY, et al
    Understanding spatio-temporal human mobility patterns for malaria control using a multi-agent mobility simulation model.
    Clin Infect Dis. 2022 Jul 19. pii: 6646427. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
21. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
    Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population.
    Clin Infect Dis. 2022 Jun 29. pii: 6619621. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. KAMAU A, Musau M, Mwakio S, Amadi D, et al
    The impact of intermittent presumptive treatment for malaria in pregnancy on hospital birth outcomes on the Kenyan coast.
    Clin Infect Dis. 2022 Jun 22. pii: 6613334. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. WEBSTER R, Mitchell H, Peters JM, Heunis J, et al
    Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Clin Infect Dis. 2022 Jun 22. pii: 6613332. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. STEFANOVA V, Ngai M, Weckman AM, Wright JK, et al
    suPAR as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria.
    Clin Infect Dis. 2022 Jun 8. pii: 6604399. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
25. HAUSER M, Kabuya JB, Mantus M, Kamavu LK, et al
    Malaria in Refugee Children Resettled to a Holoendemic Area of Sub-Saharan Africa.
    Clin Infect Dis. 2022 May 31. pii: 6595698. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. KAMAU E, Chaudhury S, Bolton JS, Slike BM, et al
    Susceptibility to HIV-1 Acquisition linked to Malaria Exposure: A Case-control Study.
    Clin Infect Dis. 2022 May 20. pii: 6589785. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
28. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Correction to: Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination Interventions.
    Clin Infect Dis. 2022 Apr 26. pii: 6574503. doi: 10.1093.
    PubMed    
    
    
    
29. IPPOLITO MM, Kabuya JB, Hauser M, Kamavu LK, et al
    Whole blood transfusion for severe malarial anemia in a high Plasmodium falciparum transmission setting.
    Clin Infect Dis. 2022 Apr 19. pii: 6570805. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
30. NAMAZZI R, Opoka R, Datta D, Bangirana P, et al
    Acute kidney injury interacts with coma, acidosis, and impaired perfusion to significantly increase risk of death in children with severe malaria.
    Clin Infect Dis. 2022 Mar 29. pii: 6555660. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
31. COPPEE R, Bailly J, Sarrasin V, Vianou B, et al
    Circulation of an artemisinin-resistant malaria lineage in a traveller returning from East Africa to France.
    Clin Infect Dis. 2022 Feb 25. pii: 6537062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. COOPER DJ, Grigg MJ, Plewes K, Rajahram GS, et al
    The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial.
    Clin Infect Dis. 2022 Feb 18. pii: 6532035. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
33. WHITE NJ, Watson JA, Simpson JA
    Severe malaria, Pascalian therapeutics and the US FDA.
    Clin Infect Dis. 2022 Jan 12. pii: 6505266. doi: 10.1093.
    PubMed    
    
    
    December 2021
34. PUTAPORNTIP C, Kuamsab N, Seethamchai S, Pattanawong U, et al
    Cryptic Plasmodium inui and P. fieldi infections among symptomatic malaria patients in Thailand.
    Clin Infect Dis. 2021 Dec 31. pii: 6491219. doi: 10.1093/cid/ciab1060.
    PubMed     Abstract available
    
    
    
35. MOHANTY S, Sahu PK, Pattnaik R, Majhi M, et al
    Evidence of Brain Alterations in Noncerebral Falciparum Malaria.
    Clin Infect Dis. 2021 Dec 15. pii: 6460593. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
    The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
    Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
    PubMed     Abstract available
    
    
    November 2021
37. ADJEI GO, Sulley AM, Goka BQ, Enweronu-Laryea C, et al
    Performance of an HRP-2 based (First Response(R)) and p-LDH-based (Optimal(R)) rapid diagnostic tests for diagnosis of malaria in paediatric sickle cell disease patients.
    Clin Infect Dis. 2021 Nov 26. pii: 6440806. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
38. YERLIKAYA S, Owusu EDA, Frimpong A, DeLisle RK, et al
    A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery.
    Clin Infect Dis. 2021 Oct 28. pii: 6413623. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. HOOFT AM, Ndenga B, Mutuku F, Otuka V, et al
    High Frequency of Antibiotic Prescription in Children With Undifferentiated Febrile Illness in Kenya.
    Clin Infect Dis. 2021;73:e2399-e2406.
    PubMed     Abstract available
    
    
    September 2021
40. BOYCE RM, Hollingsworth BD, Baguma E, Xu E, et al
    Dihydroartemisinin-piperaquine chemoprevention and malaria incidence after severe flooding: evaluation of a pragmatic intervention in rural Uganda.
    Clin Infect Dis. 2021 Sep 9. pii: 6367762. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
41. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
43. ABANYIE F, Acharya SD, Leavy I, Bowe M, et al
    Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States -April 2019 through December 2020.
    Clin Infect Dis. 2021 Jul 27. pii: 6329244. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. GARRISON A, Boivin MJ, Fievet N, Zoumenou R, et al
    The effects of malaria in pregnancy on neurocognitive development in children at one and six years of age in Benin: a prospective mother-child cohort.
    Clin Infect Dis. 2021 Jul 23. pii: 6326477. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. WANGDAHL A, Sonden K, Wyss K, Stenstrom C, et al
    Relapse of Plasmodium vivax and Plasmodium ovale malaria with and without primaquine treatment in a non-endemic area.
    Clin Infect Dis. 2021 Jul 3. pii: 6314296. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
46. DABIRA ED, Hachizovu S, Conteh B, Mendy A, et al
    Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
    Clin Infect Dis. 2021 May 13. pii: 6275208. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
47. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. MAHAMAR A, Andemel N, Swihart B, Sidibe Y, et al
    Malaria infection is common and associated with perinatal mortality and preterm delivery despite widespread use of chemoprevention in Mali: an observational study 2010 to 2014.
    Clin Infect Dis. 2021 Apr 13. pii: 6224393. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
49. ZEHNER N, Adrama H, Kakuru A, Andra T, et al
    Age-related Changes in Malaria Clinical Phenotypes During Infancy are Modified by Sickle Cell Trait.
    Clin Infect Dis. 2021 Mar 19. pii: 6178468. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. KAMALIDDIN C, Sutherland CJ, Houze S, Cottrell G, et al
    The role of ultra-sensitive molecular methods for detecting malaria - the broader perspective.
    Clin Infect Dis. 2021 Mar 9. pii: 6164943. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
    Clin Infect Dis. 2021 Mar 2. pii: 6157008. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
52. KITABI E, Bensman TJ, Earp JC, Chilukuri DM, et al
    Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: FDA Basis for Dose Determination of Artesunate for Injection in Pediatric Patients with Severe Malaria.
    Clin Infect Dis. 2021 Feb 19. pii: 6144983. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. ROUSSEL C, Ndour PA, Kendjo E, Larreche S, et al
    Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy and safety in 1391 patients.
    Clin Infect Dis. 2021 Feb 13. pii: 6134777. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. GILLETTE MA, Mani DR, Uschnig C, Pelle KG, et al
    Biomarkers to distinguish bacterial from viral pediatric clinical pneumonia in a malaria endemic setting.
    Clin Infect Dis. 2021 Feb 3. pii: 6127315. doi: 10.1093/cid/ciaa1843.
    PubMed     Abstract available
    
    
    
55. AUNG NM, Nyein PP, Kyi MM, Hanson J, et al
    Bacterial Coinfection in Adults With Severe Malaria.
    Clin Infect Dis. 2021;72:535-536.
    PubMed    
    
    
    
56. WHITE NJ
    Reply to Aung et al.
    Clin Infect Dis. 2021;72:536-538.
    PubMed    
    
    
    January 2021
57. MISCHLINGER J, Dudek V, Ramharter M
    Predictive performance of rapid diagnostic tests for falciparum malaria and its modelled impact on integrated community case management of malaria in sub-Saharan African febrile children.
    Clin Infect Dis. 2021 Jan 28. pii: 6121687. doi: 10.1093/cid/ciaa1942.
    PubMed     Abstract available
    
    
    
58. PHIRI MD, Cairns M, Zongo I, Nikiema F, et al
    The duration of protection from azithromycin against malaria, acute respiratory, gastro-intestinal and skin infections when given alongside seasonal malaria chemoprevention: secondary analyses of data from a clinical trial in Hounde, Burkina Faso and
    Clin Infect Dis. 2021 Jan 8. pii: 6071007. doi: 10.1093/cid/ciaa1905.
    PubMed     Abstract available
    
    
    
59. PETERSEN E, Grobusch MP
    Accurate malaria diagnosis: not only essential for malaria case management, but prerequisite for managing febrile disease in the tropics.
    Clin Infect Dis. 2021 Jan 4. pii: 6062465. doi: 10.1093/cid/ciaa1945.
    PubMed    
    
    
    December 2020
60. SAHU PK, Hoffmann A, Majhi M, Pattnaik R, et al
    Brain Magnetic Resonance Imaging Reveals Different Courses of Disease in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035083. doi: 10.1093/cid/ciaa1647.
    PubMed     Abstract available
    
    
    
61. JOHN CC
    Adults Are Not Big Children: What Brain Magnetic Resonance Imaging Findings Tell Us About Differences in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035081. doi: 10.1093/cid/ciaa1659.
    PubMed    
    
    
    November 2020
62. MITCHELL CL, Topazian HM, Brazeau NF, Deutsch-Feldman M, et al
    Household prevalence of P. falciparum, P. vivax, and P. ovale in the Democratic Republic of the Congo, 2013-2014.
    Clin Infect Dis. 2020 Nov 26. pii: 6006303. doi: 10.1093/cid/ciaa1772.
    PubMed     Abstract available
    
    
    September 2020
63. BERMAN JD
    Treating Severe Malaria.
    Clin Infect Dis. 2020 Sep 30. pii: 5913352. doi: 10.1093.
    PubMed    
    
    
    
64. HOUNKONNOU CPA, Ndam NT, Fievet N, Accrombessi M, et al
    Sub-optimal Intermittent Preventive Treatment in pregnancy (IPTp) is associated with an increased risk of submicroscopic P. falciparum infection in pregnant women: a prospective cohort study in Benin.
    Clin Infect Dis. 2020 Sep 9. pii: 5903262. doi: 10.1093/cid/ciaa1355.
    PubMed     Abstract available
    
    
    July 2020
65. KUBLIN JG, Murphy SC, Maenza J, Seilie AM, et al
    Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.
    Clin Infect Dis. 2020 Jul 9. pii: 5869402. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
66. JAFARI-GUEMOURI S, Courtois L, Mama A, Rouas B, et al
    A genotypical study in Benin comparing the carriage of P. falciparum infections before pregnancy and in the early pregnancy: story of a persistent infection.
    Clin Infect Dis. 2020 Jun 22. pii: 5860917. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. BUNDI CK, Nalwoga A, Lubyayi L, Muriuki JM, et al
    Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children.
    Clin Infect Dis. 2020 Jun 7. pii: 5854375. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2020
68. MAIRET-KHEDIM M, Leang R, Marmai C, Khim N, et al
    Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia.
    Clin Infect Dis. 2020 May 27. pii: 5847731. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. OPOKA RO, Waiswa A, Harriet N, John CC, et al
    Blackwater Fever in Ugandan Children With Severe Anemia is Associated With Poor Postdischarge Outcomes: A Prospective Cohort Study.
    Clin Infect Dis. 2020;70:2247-2254.
    PubMed     Abstract available
    
    
    October 2019
70. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    PubMed     Abstract available
    
    
    September 2019
71. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. HOUNKONNOU CPA, Briand V, Fievet N, Accrombessi M, et al
    Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.
    Clin Infect Dis. 2019 Sep 12. pii: 5563807. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.